Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
NCT06304168 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6150
Last updated 2026-03-03
Summary
This study explores the potential value of a new blood test approach for early detection of cancer.
Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John B. Kisiel, M.D. · Mayo Clinic in Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-13
- Primary Completion
- 2028-05-15
- Completion
- 2028-05-15
Countries
- United States
Study Locations
More Related Trials
-
Blood Cell RNA-Based Cancer Detection
NCT05839834 ·Status: RECRUITING
-
Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers
NCT05160337 ·Status: RECRUITING ·Phase: NA
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
NCT03868215 ·Status: UNKNOWN
-
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
NCT01148407 ·Status: UNKNOWN
-
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
NCT03892096 ·Status: COMPLETED
-
Cell-free DNA Methylation Markers for Cancer Screening
NCT03096938 ·Status: UNKNOWN ·Phase: NA
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer
NCT00579462 ·Status: COMPLETED
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
NCT02279004 ·Status: ACTIVE_NOT_RECRUITING
-
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
NCT00918008 ·Status: TERMINATED
-
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
NCT01434329 ·Status: COMPLETED
-
Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT05583422 ·Status: COMPLETED
-
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
NCT03071913 ·Status: COMPLETED
-
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
NCT05685524 ·Status: UNKNOWN
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Multi Institutional Study in Patient Presenting With Hematuria
NCT03122964 ·Status: UNKNOWN
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer
NCT05336058 ·Status: COMPLETED
-
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
NCT03414827 ·Status: RECRUITING
-
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
NCT05819827 ·Status: TERMINATED
-
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
NCT03071809 ·Status: TERMINATED